Joseph Bradley+FollowExosomes: Cancer’s Double Agent?Exosomes are the tiny messengers in our bodies that can either help fight cancer or help it hide! Some companies are engineering these vesicles to deliver cancer-killing drugs, while others are finding ways to stop exosomes from helping tumors grow, spread, or dodge the immune system. The wild part? Exosomes are also showing up as new cancer biomarkers and precision drug carriers. The future of cancer treatment might just ride on these microscopic couriers! #CancerResearch #Immunotherapy #Exosomes #Biotech #HealthInnovation #Health222Share
shermandarlene+FollowLung Cancer Breakthroughs You Need to KnowMajor news for small cell lung cancer: new immunotherapy combos are giving patients real hope for the first time in years! Adding the chemo drug lignin to atezolizumab can give patients three extra months without cancer getting worse. Even more exciting, a new drug called Imdelltra is helping people live over a year—way up from the usual 6-9 months. Plus, these new treatments come with fewer nasty side effects, and more patients (even those with brain mets) can join clinical trials. The future is looking brighter! #LungCancer #Immunotherapy #CancerResearch #Health140Share
April Anderson+FollowNew Cancer Drug Shows Major PromiseA new CAR T cell therapy called satri-cel just helped some late-stage stomach cancer patients live 40% longer in a clinical trial! Basically, doctors supercharged patients’ own immune cells to hunt down cancer, and the results are wild: tumors shrank in 22% of cases (vs just 4% with regular treatment), and people lived months longer on average. There are some side effects, but for folks running out of options, this is a legit breakthrough. Could this be the next big thing in cancer treatment? #CancerBreakthrough #Immunotherapy #HealthNews #Health8310Share
Charles Christensen+FollowSkin Cancer Breakthrough: One-Time Fix?A one-time therapy is shaking up the fight against deadly skin cancer! In a new trial, nearly 1 in 5 people with advanced melanoma lived for five years after getting lifileucel—a treatment that supercharges your own immune cells to attack tumors. Even crazier: almost 80% saw their tumors shrink, and some had no cancer left at all. It’s not approved everywhere yet, but this could be a total game-changer for people with few options left. Major hope for the future! #CancerBreakthrough #Melanoma #Immunotherapy #Health281Share
Michelle Welch+FollowGame-Changer for Skin Cancer?A new treatment called lifileucel is turning heads—using your own immune cells to fight advanced melanoma! In a recent trial, nearly 1 in 5 patients lived five years longer, and most saw their tumors shrink. One participant even went into complete remission just six weeks after treatment. This could be a total game-changer for people with tough-to-treat skin cancer. Would you try a therapy that uses your own cells to fight back? #CancerBreakthrough #Melanoma #Immunotherapy #Health202Share
Joseph Bradley+FollowGame-Changer for Stomach Cancer?Big news from the ASCO conference: adding the immunotherapy drug durvalumab (Imfinzi) to standard chemo before and after surgery for stomach and GEJ cancers keeps the disease under control longer! In the MATTERHORN trial, this combo cut the risk of cancer coming back or getting worse by 29%. Docs are calling it practice-changing—looks like more patients could be cured with this new approach. If you or someone you know is facing surgery for stomach cancer, this could be a huge deal! #CancerResearch #Immunotherapy #ASCO2025 #Health80Share
Jacqueline Howard DDS+FollowCancer Breakthrough: 5 Years Remission?!Major chills: a new immunotherapy drug, pembrolizumab, is doubling the time head and neck cancer stays away compared to old-school treatments. We’re talking five years cancer-free for some patients, instead of just 30 months! This is the biggest leap in 20 years, and it works even better for people with high immune markers—but it’s helping everyone. One patient called it the ‘gift of life.’ Huge hope for anyone facing these cancers! #CancerBreakthrough #Immunotherapy #MedicalNews #Health35031Share
Ryan Lewis+FollowCancer Drug Doubles Remission Time!Major breakthrough alert: a new trial found that the immunotherapy drug pembrolizumab (Keytruda) kept head and neck cancer away for FIVE years—double what standard treatments do! Not only did it slash the risk of cancer coming back somewhere else, but it also worked for all patients, not just those with certain immune markers. After 20+ years of the same old treatments, this could be a total game-changer for thousands facing head and neck cancer. #CancerBreakthrough #Immunotherapy #Keytruda #Health10912Share
Jacqueline Howard DDS+FollowNew Antibody Could Supercharge Cancer ImmunityScientists just dropped a game-changer: an antibody called PLT012 that blocks a fat transporter (CD36) in tumors. Basically, it stops cancer from hijacking your immune cells with fatty snacks, letting your body fight back—even against cancers that usually ignore immunotherapy. Early tests in mice and monkeys look super promising, and it might work for more than just liver cancer. Could this be the next big thing in cancer treatment? #CancerResearch #Immunotherapy #MedicalBreakthrough #ScienceNews #Health19326Share
Kristi Key+FollowCancer-Fighting Antibodies Just Got a Glow-UpScientists have just amped up our immune system’s cancer-fighting game by engineering super-rigid antibodies. These new Y-shaped proteins are like the body’s bouncers—tougher, stronger, and way better at kicking cancer cells out. By tweaking their structure, researchers found these antibodies trigger a much stronger immune response than the usual ones. Early tests look super promising for future cancer treatments. Could this be the next big leap in immunotherapy? Stay tuned! #CancerResearch #Immunotherapy #ScienceNews #MedicalBreakthrough #HealthInnovation #Health130Share
